ExitOdds Method

Ranking · Winter 2015 · Healthcare · Diagnostics

X-Zell

Early, pain-free cancer detection.

3.5%

odds of being acquired in the next two years

0.5× the average (6.8%)

#4236 of 4,339 active YC companies · top 99%

Team of 19 · Bangkok, Thailand; Düsseldorf, NRW, Germany

Raises the odds

↑ based in Remote

Lowers the odds

↓ industry: Healthcare

↓ based in Southeast Asia

↓ sector: Diagnostics

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads X-Zell's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub